APOL1 Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K Variant

APOL1 Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K Variant

Bibliographic Details
Main Authors:	Rasheed Gbadegesin, Elena Martinelli, Yask Gupta, David J. Friedman, Matthew G. Sampson, Martin R. Pollak, Simone Sanna-Cherchi
Format:	Article
Language:	English
Published:	Karger Publishers 2024-02-01
Series:	Glomerular Diseases
Subjects:	apol1 genetic modifier focal segmental glomerulosclerosis
Online Access:	https://beta.karger.com/Article/FullText/537948

Similar Items

Collapsing Focal Segmental Glomerulosclerosis in Siblings With Compound Heterozygous Variants in NUP93 Expand the Spectrum of Kidney Phenotypes Associated With Nucleoporin Gene Mutations
by: Rachel K. Cason, et al.
Published: (2022-07-01)

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
by: Gizelle M. McCarthy, et al.
Published: (2021-08-01)

APOL1 Gene Variants and Risk for Cardiovascular Disease
by: Carlos Eduardo Duran, et al.
Published: (2023-12-01)

Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults
by: Ogo Egbuna, et al.
Published: (2024-03-01)

APOL1 variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress
by: Ashira Blazer, et al.
Published: (2022-09-01)

Association of APOL1 Genotypes With Measures of Microvascular and Endothelial Function, and Blood Pressure in MESA
by: Teresa K. Chen, et al.
Published: (2020-09-01)

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
by: Michael D. Hughson, et al.
Published: (2018-01-01)

APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients
by: Teresa K. Chen, et al.
Published: (2021-02-01)

APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway
by: Jun-yi Zhu, et al.
Published: (2023-12-01)

COVID-19–Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases
by: Yuvraj Sharma, et al.
Published: (2020-07-01)

Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression
by: Ping An, et al.
Published: (2019-01-01)

Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells
by: Maty Tzukerman, et al.
Published: (2022-01-01)

Lessons From APOL1 Animal Models
by: Teruhiko Yoshida, et al.
Published: (2021-10-01)

APOL1 Risk Alleles Are Associated With More Severe Arteriosclerosis in Renal Resistance Vessels With Aging and Hypertension
by: Michael D. Hughson, et al.
Published: (2016-05-01)

APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) StudiesPlain-Language Summary
by: Anthony Nguyen, et al.
Published: (2022-12-01)

HIV Viremia Is Associated With APOL1 Variants and Reduced JC-Viruria
by: Etty Kruzel-Davila, et al.
Published: (2021-08-01)

Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi‐Ethnic Study of Atherosclerosis)
by: Teresa K. Chen, et al.
Published: (2017-12-01)

APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma
by: Hua Zhu, et al.
Published: (2022-09-01)

Association between APOL1 risk variants and the occurrence of sepsis in Black patients hospitalized with infections: a retrospective cohort study
by: Lan Jiang, et al.
Published: (2023-10-01)

APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress
by: Hidefumi Wakashin, et al.
Published: (2020-08-01)

Collapsing glomerulopathy following COVID 19 infection; a mini-review to the recent data
by: Leila Alem, et al.
Published: (2023-10-01)

APOL1 Risk Variants Associate With the Prevalence of Stroke in African American Current and Past Smokers
by: Jelena Mustra Rakic, et al.
Published: (2023-12-01)

Apolipoprotein L1 (APOL1) Variants (Vs) a Possible Link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN)
by: Xiqian eLan, et al.
Published: (2015-06-01)

Association Between APOL1 Genotype and Kidney Diseases and Annual Kidney Function Change: A Systematic Review and Meta-Analysis of the Prospective Studies
by: Jagannathan R, et al.
Published: (2021-04-01)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
by: Jin Han, et al.
Published: (2021-08-01)

Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
by: Phuong Anh Le Thy, et al.
Published: (2022-09-01)

Loss of phosphatidylserine flippase β-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis
by: Wenjing Liu, et al.
Published: (2021-06-01)

IFI16 Is Indispensable for Promoting HIF-1α-Mediated APOL1 Expression in Human Podocytes under Hypoxic Conditions
by: Richaundra K. Randle, et al.
Published: (2024-03-01)

ERDOĞAN VERSUS GÜLEN: Perebutan Pengaruh antara Islam Politik Post-Islamis dengan Islam Kultural Apolitis
by: Akhmad Rizqon Khamami
Published: (2016-11-01)

APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
by: Barry I. Freedman, et al.
Published: (2017-07-01)

Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR
by: Murat Dogan, et al.
Published: (2024-04-01)

Adult-Onset Genetic Focal Segmental Glomerulosclerosis: A Tale of Two Mutations
by: Luís Leite de Sousa, et al.
Published: (2023-03-01)

A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes
by: Jin-Gu Lee, et al.
Published: (2023-11-01)

Histopathological analysis of the non - tumour parenchyma following radical nephrectomy: can it predict renal functional outcome?
by: Rana Birendra, et al.

A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood
by: Tsuji Kenji, et al.
Published: (2012-06-01)

Apol9a regulates myogenic differentiation via the ERK1/2 pathway in C2C12 cells
by: Xuan Jiang, et al.
Published: (2022-11-01)

APOL1, Sickle Cell Trait, and CKD in the Jackson Heart StudyPlain-Language Summary
by: Bessie A. Young, et al.
Published: (2021-11-01)

Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6
by: Grace R. Raji, et al.
Published: (2021-05-01)

Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive Management
by: Thomas M. Schneider, et al.
Published: (2021-05-01)

Molecular Dynamic Simulation Reveals Structure Differences in <i>APOL1</i> Variants and Implication in Pathogenesis of Chronic Kidney Disease
by: Richard Mayanja, et al.
Published: (2022-08-01)